{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:49:25Z","timestamp":1789001365718,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1038\/mt.2016.175","type":"journal-article","created":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T11:30:22Z","timestamp":1476271822000},"page":"2078-2089","source":"Crossref","is-referenced-by-count":50,"title":["Targeted Delivery of an Anti-inflammatory PDE4 Inhibitor to Immune Cells via an Antibody\u2013drug Conjugate"],"prefix":"10.1016","volume":"24","author":[{"given":"Shan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron D","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyna KV","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly B","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Weglarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric N","family":"Hampton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Bollong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Zambaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley K","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A","family":"Kazane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis S","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2016.175_bib1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.canlet.2007.04.010","article-title":"Cell killing by antibody-drug conjugates","volume":"255","author":"Kovtun","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1038\/mt.2016.175_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1021\/bc9002019","article-title":"Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies","volume":"21","author":"Ducry","year":"2010","journal-title":"Bioconjug Chem"},{"key":"10.1038\/mt.2016.175_bib3","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/mt.2012.103","article-title":"Targeting the hemoglobin scavenger receptor CD163 in macrophages highly increases the anti-inflammatory potency of dexamethasone","volume":"20","author":"Graversen","year":"2012","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.175_bib4","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1021\/acs.bioconjchem.5b00203","article-title":"Targeted delivery of LXR agonist using a site-specific antibody-drug conjugate","volume":"26","author":"Lim","year":"2015","journal-title":"Bioconjug Chem"},{"key":"10.1038\/mt.2016.175_bib5","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1021\/jacs.5b00620","article-title":"An immunosuppressive antibody-drug conjugate","volume":"137","author":"Wang","year":"2015","journal-title":"J Am Chem Soc"},{"key":"10.1038\/mt.2016.175_bib6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"Maurice","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"Pt 1","key":"10.1038\/mt.2016.175_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20021698","article-title":"PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization","volume":"370","author":"Houslay","year":"2003","journal-title":"Biochem J"},{"key":"10.1038\/mt.2016.175_bib8","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.2174\/138161210794079209","article-title":"Phosphodiesterase 4 inhibitors in inflammatory bowel disease: a comprehensive review","volume":"16","author":"Salari-Sharif","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1038\/mt.2016.175_bib9","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1186\/ar3041","article-title":"Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis","volume":"12","author":"McCann","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1038\/mt.2016.175_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jaad.2015.03.049","article-title":"Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)","volume":"73","author":"Papp","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/mt.2016.175_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1465-9921-11-26","article-title":"The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma","volume":"11","author":"Singh","year":"2010","journal-title":"Respir Res"},{"key":"10.1038\/mt.2016.175_bib12","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1021\/jm5001216","article-title":"Efficacious inhaled PDE4 inhibitors with low emetic potential and long duration of action for the treatment of COPD","volume":"57","author":"De Savi","year":"2014","journal-title":"J Med Chem"},{"key":"10.1038\/mt.2016.175_bib13","first-page":"1236","article-title":"AN-2728, a PDE4 inhibitor for the potential topical treatment of psoriasis and atopic dermatitis","volume":"10","author":"Nazarian","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1038\/mt.2016.175_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1124\/jpet.110.173690","article-title":"GSK256066, an exceptionally high-affinity and selective inhibitor of phosphodiesterase 4 suitable for administration by inhalation: in vitro, kinetic, and in vivo characterization","volume":"337","author":"Tralau-Stewart","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1038\/mt.2016.175_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/jpet.110.173641","article-title":"In vivo characterization of GSK256066, a high-affinity inhaled phosphodiesterase 4 inhibitor","volume":"337","author":"Nials","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1038\/mt.2016.175_bib16","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.pupt.2013.05.004","article-title":"Safety and tolerability of the inhaled phosphodiesterase 4 inhibitor GSK256066 in moderate COPD","volume":"26","author":"Watz","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1038\/mt.2016.175_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000077660","article-title":"T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): mechanisms of action","volume":"208","author":"Jullien","year":"2004","journal-title":"Dermatology"},{"key":"10.1038\/mt.2016.175_bib18","first-page":"301","article-title":"Efalizumab in the treatment of psoriasis","volume":"1","author":"Boehncke","year":"2007","journal-title":"Biologics"},{"key":"10.1038\/mt.2016.175_bib19","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1016\/j.bmcl.2009.04.012","article-title":"Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administration","volume":"19","author":"Woodrow","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1038\/mt.2016.175_bib20","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrd3270","article-title":"Antibody-drug conjugates for cancer: poised to deliver?","volume":"9","author":"Hughes","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1038\/mt.2016.175_bib21","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1182\/blood-2011-04-347252","article-title":"LFA-1 blockade induces effector and regulatory T-cell enrichment in lymph nodes and synergizes with CTLA-4Ig to inhibit effector function","volume":"118","author":"Reisman","year":"2011","journal-title":"Blood"},{"key":"10.1038\/mt.2016.175_bib22","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/dmd.104.002584","article-title":"Tissue distribution and receptor-mediated clearance of anti-CD11a antibody in mice","volume":"33","author":"Coffey","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1038\/mt.2016.175_bib23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/09629359791901","article-title":"Carrageenan-induced acute inflammation in the mouse air pouch synovial model. Role of tumour necrosis factor","volume":"6","author":"Romano","year":"1997","journal-title":"Mediators Inflamm"},{"key":"10.1038\/mt.2016.175_bib24","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1084\/jem.20092695","article-title":"Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response","volume":"207","author":"Swanson","year":"2010","journal-title":"J Exp Med"},{"key":"10.1038\/mt.2016.175_bib25","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1073\/pnas.1118104109","article-title":"Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation","volume":"109","author":"O'Boyle","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2016.175_bib26","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1038\/ncomms8064","article-title":"Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growth","volume":"6","author":"Satpathy","year":"2015","journal-title":"Nat Commun"},{"key":"10.1038\/mt.2016.175_bib27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/bjp.2008.307","article-title":"PDE4 inhibitors: current status","volume":"155","author":"Spina","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1038\/mt.2016.175_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1358\/mf.2002.24.3.802297","article-title":"Pica in mice as a new model for the study of emesis","volume":"24","author":"Yamamoto","year":"2002","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1038\/mt.2016.175_bib29","doi-asserted-by":"crossref","first-page":"583","DOI":"10.4161\/mabs.1.6.9884","article-title":"Monoclonal antibodies and progressive multifocal leukoencephalopathy","volume":"1","author":"Berger","year":"2009","journal-title":"MAbs"},{"key":"10.1038\/mt.2016.175_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.med.080708.082655","article-title":"Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies","volume":"61","author":"Major","year":"2010","journal-title":"Annu Rev Med"},{"key":"10.1038\/mt.2016.175_bib31","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/art.22643","article-title":"The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5\u2032-nucleotidase: findings in a study of ecto-5\u2032-nucleotidase gene-deficient mice","volume":"56","author":"Montesinos","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1038\/mt.2016.175_bib32","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4049\/jimmunol.168.2.853","article-title":"Activation of the stem cell-derived tyrosine kinase\/RON receptor tyrosine kinase by macrophage-stimulating protein results in the induction of arginase activity in murine peritoneal macrophages","volume":"168","author":"Morrison","year":"2002","journal-title":"J Immunol"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616454663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616454663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T18:53:45Z","timestamp":1536346425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616454663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1525001616454663"],"URL":"https:\/\/doi.org\/10.1038\/mt.2016.175","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}